TAMPA, Fla., Jan. 27, 2026 (GLOBE NEWSWIRE) -- AtlasClear Holdings, Inc. (NYSE American: ATCH) (“AtlasClear” or the “Company”), a technology-enabled financial services platform modernizing trading, clearing, settlement, and banking, today reported on fiscal 2025 balance sheet transformation, improved operating momentum, and strategic priorities for 2026. Fiscal 2025: Rebuilding the Foundation… Read More..

Confirmation Received from MHLW That QRX003 Qualifies for Both Orphan Drug Designation and Fast Track Regulatory Review Status Quoin Initiating the Establishment of a Japanese Subsidiary to Facilitate Self-Commercialization of QRX003 in Japan, if Approved Orphan Drug Designation Previously Granted by Both the U.S. Food and Drug Administration (FDA) and… Read More..

Investment Brings a Total of $14 Million to SKYX in Recent Funding Over the Past 3 Months from Strategic Investors and Long-Term Shareholders as SKYX continues its Market Penetration and Path to Cash Flow Positive MIAMI, Jan. 14, 2026 (GLOBE NEWSWIRE) -- SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies)… Read More..